ASAP ASCENDIS SIGNATURE ACCESS PROGRAM

Serial Number 90557693
Registration 7342066
700

Registration Progress

Application Filed
Mar 3, 2021
Under Examination
Approved for Publication
Jan 16, 2024
Published for Opposition
Jan 16, 2024
Registered
Apr 2, 2024

Trademark Image

ASAP ASCENDIS SIGNATURE ACCESS PROGRAM

Basic Information

Serial Number
90557693
Registration Number
7342066
Filing Date
March 3, 2021
Registration Date
April 2, 2024
Published for Opposition
January 16, 2024
Drawing Code
3000

Status Summary

Current Status
Active
Status Code
700
Status Date
Apr 2, 2024
Registration
Registered
Classes
044

Rights Holder

Ascendis Pharma A/S

99
Address
Tuborg Boulevard 12
Hellerup 2900
DK

Ownership History

Ascendis Pharma A/S

Original Applicant
99
Hellerup DK

Ascendis Pharma A/S

Owner at Publication
99
Hellerup DK

Ascendis Pharma A/S

Original Registrant
99
Hellerup DK

Legal Representation

Attorney
Shannon Marie McKeon

USPTO Deadlines

Next Deadline
1723 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-04-02)
Due Date
April 02, 2030
Grace Period Ends
October 02, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

38 events
Date Code Type Description
Apr 2, 2024 R.PR A REGISTERED-PRINCIPAL REGISTER
Apr 2, 2024 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED
Feb 6, 2024 ISPO Z WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Feb 6, 2024 CHPB I CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Feb 5, 2024 APET A ASSIGNED TO PETITION STAFF
Jan 16, 2024 PUBO A PUBLISHED FOR OPPOSITION
Jan 16, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 27, 2023 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Dec 27, 2023 EPPA I TEAS POST PUBLICATION AMENDMENT RECEIVED
Dec 12, 2023 CNEA R EXAMINERS AMENDMENT -WRITTEN
Dec 12, 2023 GNEA O EXAMINERS AMENDMENT E-MAILED
Dec 12, 2023 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Dec 12, 2023 XAEC I EXAMINER'S AMENDMENT ENTERED
Dec 12, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 14, 2023 ZZZX Z PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 26, 2023 PBCR Z WITHDRAWN FROM PUB - OG REVIEW QUERY
Sep 11, 2023 FIXD O ELECTRONIC RECORD REVIEW COMPLETE
Sep 8, 2023 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Sep 6, 2023 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 8, 2023 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 13, 2023 ERSI I TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 19, 2022 RCSC S REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Nov 30, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Nov 29, 2022 DOCK D ASSIGNED TO EXAMINER
Nov 23, 2022 RCCK S SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Apr 19, 2022 CNSL R SUSPENSION LETTER WRITTEN
Apr 19, 2022 GNSL S LETTER OF SUSPENSION E-MAILED
Apr 19, 2022 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 23, 2022 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 23, 2022 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2022 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 26, 2021 CNRT R NON-FINAL ACTION WRITTEN
Sep 26, 2021 GNRT F NON-FINAL ACTION E-MAILED
Sep 26, 2021 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 25, 2021 DOCK D ASSIGNED TO EXAMINER
Jun 3, 2021 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED
Jun 2, 2021 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2021 NWAP I NEW APPLICATION ENTERED

Detailed Classifications

Class 044
Patient support program, namely, providing health care information to patients and healthcare providers in the field of growth hormone deficiency, endocrine disorders, and bone and skeletal disorders diagnosis and treatment including providing information on self-administering medications; administering a quick start patient assistance program to provide patients with limited free supplies of drugs to initiate therapy while obtaining benefits or insurance coverage
First Use Anywhere: 0
First Use in Commerce: 0

Additional Information

Design Mark
The mark consists of the stylized wording "ASAP", with small diamonds between the letters, and the stylized wording "ASCENDIS SIGNATURE ACCESS PROGRAM" underneath.

Classification

International Classes
044

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ACCESS PROGRAM"

USPTO Documents

Loading USPTO documents...